Telcon Inc (200230) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.013x

Based on the latest financial reports, Telcon Inc (200230) has a cash flow conversion efficiency ratio of 0.013x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.37 Billion ≈ $926.20K USD) by net assets (₩108.82 Billion ≈ $73.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Telcon Inc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Telcon Inc - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Telcon Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Telcon Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Telcon Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Dynamic Metals Ltd
AU:DYM
-0.033x
TOMI Environmental Solutions Inc
NASDAQ:TOMZ
537.365x
Hanil Chemical Ind. Co. Ltd
KQ:007770
-0.009x
SenzaGen AB
ST:SENZA
-0.052x
Multi Indocitra Tbk
JK:MICE
-0.016x
Holista Colltech Ltd
AU:HCT
-0.382x
GENOMTEC S.A. ZY -10
F:4VI
N/A
Diagnos Laboratorium Utama PT Tbk
JK:DGNS
0.008x

Annual Cash Flow Conversion Efficiency for Telcon Inc (2013–2025)

The table below shows the annual cash flow conversion efficiency of Telcon Inc from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Telcon Inc.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩108.82 Billion
≈ $73.74 Million
₩1.67 Billion
≈ $1.13 Million
0.015x +4.46%
2024-12-31 ₩83.13 Billion
≈ $56.34 Million
₩1.22 Billion
≈ $825.99K
0.015x +235.60%
2023-12-31 ₩104.94 Billion
≈ $71.12 Million
₩-1.13 Billion
≈ $-768.96K
-0.011x +56.54%
2022-12-31 ₩84.12 Billion
≈ $57.01 Million
₩-2.09 Billion
≈ $-1.42 Million
-0.025x -639.51%
2021-12-31 ₩106.58 Billion
≈ $72.23 Million
₩-358.56 Million
≈ $-242.99K
-0.003x -110.96%
2020-12-31 ₩91.34 Billion
≈ $61.90 Million
₩2.80 Billion
≈ $1.90 Million
0.031x -30.20%
2019-12-31 ₩114.02 Billion
≈ $77.27 Million
₩5.01 Billion
≈ $3.40 Million
0.044x +173.22%
2018-12-31 ₩154.03 Billion
≈ $104.38 Million
₩-9.25 Billion
≈ $-6.27 Million
-0.060x +34.47%
2017-12-31 ₩107.69 Billion
≈ $72.98 Million
₩-9.87 Billion
≈ $-6.69 Million
-0.092x -22.16%
2016-12-31 ₩65.96 Billion
≈ $44.70 Million
₩-4.95 Billion
≈ $-3.35 Million
-0.075x -245.56%
2015-12-31 ₩43.99 Billion
≈ $29.81 Million
₩2.27 Billion
≈ $1.54 Million
0.052x +51.13%
2014-12-31 ₩43.21 Billion
≈ $29.28 Million
₩1.47 Billion
≈ $998.50K
0.034x -93.92%
2013-12-31 ₩22.51 Billion
≈ $15.25 Million
₩12.62 Billion
≈ $8.55 Million
0.561x --

About Telcon Inc

KQ:200230 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$17.45 Million
₩25.75 Billion KRW
Market Cap Rank
#25557 Global
#1858 in Korea
Share Price
₩360.00
Change (1 day)
-0.28%
52-Week Range
₩360.00 - ₩10340.00
All Time High
₩18250.00
About

TELCON RF PHARMACEUTICAL. Inc. primarily engages in the development, production, and sale of RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies; and pharmaceuticals. The company was formerly known as Telcon Co., Ltd. TELCON RF PHARMACEUTICAL. Inc. was founded in 1999 and is headquartered in Yongin-si, South Korea.